{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:53:07Z","timestamp":1787165587921,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.antiviral.2020.104857","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T21:33:39Z","timestamp":1592429619000},"page":"104857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4592-5280","authenticated-orcid":false,"given":"Steffen","family":"Jockusch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8076-3985","authenticated-orcid":false,"given":"Thomas K.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minchen","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-2709","authenticated-orcid":false,"given":"Robert N.","family":"Kirchdoerfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4974-4241","authenticated-orcid":false,"given":"Jingyue","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104857_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01348-19","article-title":"Small-molecule antiviral \u03b2-d-N4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance","volume":"93","author":"Agostini","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104857_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/mthe.2001.0315","article-title":"Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo","volume":"3","author":"Aky\u00fcrek","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2020.104857_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acsmedchemlett.8b00586","article-title":"The ProTide prodrug technology: where next?","volume":"10","author":"Alanazi","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2020.104857_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkq447","article-title":"Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection","volume":"66","author":"Anderson","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104857_bib5","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1021\/bi00155a016","article-title":"2\u2019-Fluoro and 2\u2019-amino-2\u2019-deoxynucleoside 5\u2019-triphosphates as substrates for T7 RNA polymerase","volume":"31","author":"Arup","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104857_bib6","doi-asserted-by":"crossref","first-page":"9372","DOI":"10.1073\/pnas.1201130109","article-title":"RNA 3\u2019-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10\/nsp14 exoribonuclease complex","volume":"109","author":"Bouvet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104857_bib7","article-title":"Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase","author":"Chien","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.antiviral.2020.104857_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2020.104857_bib9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.cmi.2016.08.025","article-title":"Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy","volume":"22","author":"Dustin","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2020.104857_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104857_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104857_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000896","article-title":"Infidelity of SARS-CoV nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing","volume":"6","author":"Eckerle","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104857_bib13","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, Sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.antiviral.2020.104857_bib14","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.3390\/v7102868","article-title":"Inhibitors of the hepatitis C virus polymerase; mode of action and resistance","volume":"7","author":"Eltahla","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104857_bib15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/AAC.41.5.1099","article-title":"Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89","volume":"41","author":"Faletto","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104857_bib16","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1073\/pnas.1718806115","article-title":"Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA","volume":"115","author":"Ferron","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104857_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104857_bib18","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104857_bib19","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104857_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/AAC.33.6.844","article-title":"Cellular pharmacology of 2\u2019,3\u2019-dideoxy-2\u2019,3\u2019-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus","volume":"33","author":"Ho","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104857_bib21","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/S0021-9258(18)45952-2","article-title":"Selective action of 2\u2019,3\u2019-didehydro-2\u2019,3\u2019-dideoxythymidine triphosphate on human immunodeficiency virus reverse transcriptase and human DNA polymerases","volume":"267","author":"Huang","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104857_bib22","article-title":"Triphosphates of the two components in DESCOVY and TRUVADA are inhibitors of the SARS-CoV-2 polymerase","author":"Jockusch","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.antiviral.2020.104857_bib23","doi-asserted-by":"crossref","first-page":"19635","DOI":"10.1073\/pnas.0609513103","article-title":"Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators","volume":"103","author":"Ju","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104857_bib24","article-title":"Nucleotide analogues as inhibitors of SARS-CoV polymerase","author":"Ju","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.antiviral.2020.104857_bib25","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","article-title":"Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors","volume":"10","author":"Kirchdoerfer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104857_bib26","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3390\/v2122740","article-title":"Development of CMX001 for the treatment of poxvirus infections","volume":"2","author":"Lanier","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104857_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cbic.201100648","article-title":"Enzymatic recognition of 2\u2019-modified ribonucleoside 5\u2019-triphosphates: towards the evolution of versatile aptamers","volume":"13","author":"Lauridsen","year":"2012","journal-title":"Chembiochem"},{"key":"10.1016\/j.antiviral.2020.104857_bib28","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex","volume":"112","author":"Ma","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104857_bib29","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.49.8.3153-3162.2005","article-title":"Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate","volume":"49","author":"Magee","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104857_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clinthera.2006.02.012","article-title":"Entecavir for the treatment of chronic hepatitis B virus infection","volume":"28","author":"Matthews","year":"2006","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.antiviral.2020.104857_bib31","doi-asserted-by":"crossref","first-page":"S490","DOI":"10.1093\/clinids\/10.Supplement_3.S490","article-title":"Antiviral activity and mechanism of action of ganciclovir","volume":"10","author":"Matthews","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104857_bib32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.01122-07","article-title":"Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition","volume":"52","author":"Mazzucco","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104857_bib33","first-page":"1","article-title":"Inhibitors of viral nucleic acid polymerases. Pyrophosphate analogues","volume":"401","author":"McKenna","year":"1989","journal-title":"ACS (Am. Chem. Soc.) Symp. Ser."},{"key":"10.1016\/j.antiviral.2020.104857_bib34","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0508200103","article-title":"Discovery of an RNA virus 3\u2019\u21925\u2019 exoribonuclease that is critically involved in coronavirus RNA synthesis","volume":"103","author":"Minskaia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104857_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2006.05.012","article-title":"Rational design of polymerase inhibitors as antiviral drugs","volume":"71","author":"\u00d6berg","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104857_bib36","doi-asserted-by":"crossref","first-page":"40479","DOI":"10.1074\/jbc.M205303200","article-title":"Mechanistic studies to understand the progressive development of resistance in human immunodeficiency virus type 1 reverse transcriptase to abacavir","volume":"277","author":"Ray","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104857_bib37","first-page":"721","article-title":"Chronic hepatitis B: current and future treatment options","volume":"22","author":"Rivkina","year":"2002","journal-title":"Pharma"},{"key":"10.1016\/j.antiviral.2020.104857_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/v10020059","article-title":"Structural and functional basis of the fidelity of nucleotide selection by Flavivirus RNA-dependent RNA polymerases","volume":"10","author":"Selisko","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104857_bib39","doi-asserted-by":"crossref","first-page":"104793","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites","volume":"178","author":"Shannon","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104857_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2020.104857_bib41","doi-asserted-by":"crossref","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104857_bib42","doi-asserted-by":"crossref","first-page":"34218","DOI":"10.1074\/jbc.M806797200","article-title":"Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase","volume":"283","author":"Tchesnokov","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104857_bib43","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00018-014-1695-z","article-title":"Common and unique features of viral RNA-dependent polymerases","volume":"71","author":"te Velthuis","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2020.104857_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2015.02.007","article-title":"The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease","volume":"117","author":"Trost","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104857_bib45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104857_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2013 drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:16Z","timestamp":1759062736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":46,"alternative-id":["S0166354220302710"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104857","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.23.058776","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104857"}}